The major COVID variants we've seen so far and which one to look out for right now
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
Cautious Outlook on Moderna: Declining Vaccine Demand and Strategic Challenges Prompt Sell Rating
Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...
14 out of 18 healthcare companies beat profit estimates this week- Earnings scorecard
Healthcare sector earnings report summary: 14 companies beat profit estimates, with major players like Viatris, Gilead ...
Earnings Scorecard: About 50% of companies that reported earnings this week beat estimates
U.S. markets finished higher this week after the Federal Reserve cut its key interest rate, extending record highs logged ...
GEN1d
StockWatch: Wall Street Weighs Trump Effect on Biopharma, from Vaccines to M&A
[emphasis in original] Yee cited by name Moderna (NASDAQ: MRNA) as an example of a vaccine developer hurt by declining ...
Jury awards $12M to woman fired for refusing COVID vax. Hundreds of similar suits pending.
The Wyandotte woman had worked at Blue Cross for 32 years and was denied a religious accommodation to the insurer's vaccine ...
MedPage Today2d
When's the Best Time to Get Your Flu and COVID Shots?
Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters -- they're not just another dose of ...
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...
2 Biotech Stocks You Can Buy Hand Over Fist This Month
Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...
Cautious Outlook for Moderna Amid Market Challenges and Shrinking Growth Prospects
Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Moderna (MRNA – Research Report) today and set a price ...
Hosted on MSN2d
Canada approves Moderna's RSV vaccine for adults aged 60 and older
(Reuters) -Moderna said on Friday Canada's health regulator has ... including mRESVIA and an experimental COVID-flu ...
devdiscourse2d
FDA Advances Heart Device; Trump Vaccine Pledge in Question
Recent health news includes the FDA's approval of Johnson & Johnson's heart device, calls for President-elect Trump to honor vaccine pledges for Africa, and the proposed removal of phenylephrine by ...